Marc Stapley - Feb 27, 2025 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Feb 27, 2025
Transactions value $
-$1,866,261
Form type
4
Date filed
3/3/2025, 04:30 PM
Previous filing
Dec 17, 2024
Next filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Award $0 +67.3K +21.84% $0.00 375K Feb 27, 2025 Direct F1, F2
transaction VCYT Common Stock Tax liability -$1.16M -34.3K -9.13% $33.84 341K Feb 27, 2025 Direct F3
transaction VCYT Common Stock Tax liability -$706K -20.3K -5.96% $34.76 321K Mar 2, 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein.
F2 Includes 707 shares of common stock purchased on January 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
F3 Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.
F4 The reporting person is reporting the withholding of 1,486, 1,795, 2,478 and 14,565 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925, 3,533, 4,878 and 28,681 Restricted Stock Units granted on June 1, 2021, March 3, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.